2m 2m 2m 2m 2m 2m 2m
IMPACT BIO (IBO)
NYSE
$0.54-$0.002 (-0.35%)
Price as of Jun 23, 2026 7:10 PM EDT- $57.4MMarket Cap
- -66.95%1-Year Change
- BiotechnologyIndustry
IMPACT BIO (IBO)
$0.54-$0.002 (-0.35%)
IBO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | +$0.03 (+5.95%) | ||
Open | $0.52 | ||
High | $0.54 | ||
Low | $0.52 | ||
Previous Close | $0.53 | ||
Volume | 67,374 | ||
30-Day Average Volume | 76,671 | ||
1-Week Change | -3.61% | ||
1-Month Change | -2.15% | ||
1-Year Change | -66.95% | ||
3-Year Change | -97.86% | ||
5-Year Change | -97.86% | ||
Fundamentals | |||
Shares Outstanding | 107.8M | ||
Total Assets | $17.1M | ||
Market Cap | $57.4M | ||
Enterprise Value | $66.5M | ||
Period: QTR TTM FY | |||
Revenue | $7,000.00 | ||
Net Income | -$2.3M | ||
Free Cash Flow | -$464,000.00 | ||
EBIT | -$2.3M | ||
EBITDA | -$2.0M | ||
Net Working Capital | -$1.3M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 9,499 | ||
P/B | 5 | ||
P/E | -27 | ||
PEG | 0 | ||
Price/Free Cash Flow | -124 | ||
Price/Operating Cash Flow | -124 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue